| Home | E-Submission | Sitemap | Contact Us |  
The Korean Journal of Pathology 1979;13(3): 179-186.
Gamma-Glutamyl Transpepidase 활성도의 임상 진단적 의의에 관한 연구
A Study on Clinical Diagnostic Value of Serum Gamma-Glutamyl Transpeptidase Activity
The enzyme Gamma-Glutamyl Transpeptidase (γ-GT, EC is distributed widely throughout the body, highest activities being present in the kidney, followed by pancreas, liver, spleen, and brain. It catalyses transfer of the gamma-glutamyl group from gama glutamyl peptides to other peptides or any of the common amino acids except proline. Since a group of Polish investigators first reported elevated γ-GT activity in sere of Patients with hepatic disease, a number of reports have appeared describing the conditions in which there is an elevated serum γ-GT activity. The level of γ-GT has been shown to be raised mainly in patients with hepato-biliary disease and to a lesser extent in a number of other conditions as Pancreatic, heart, neurologic, and renal diseases. As the Department of Clinical Pathology, Yonsei University Medical College, has recently purchased the autoanalyzer System 5 (Gilford Instrument Laboratories, Inc.), the rapid and_accurate determination of serum γ-GT activity has ben made possible. The author measured he activity in sera from the patients with a variety of diseases and 30 normal controls comprised of healthy medical students by using System 5. The results are as follows. 1. The average values of γ-GT for normal controls were 19.2 IU/L (range 8-33 IU/L) in male, and 16.5 IU/L (range 6-28 IV/L) in female, respectively. 2. Patients with all forms of hepato-biliary diseases had elevated serum γ-GT level. The highest activity was noted in patients with cholecystits or cholelithiasis. 3. Patients with primary hepatocellular and metastatic carcinomas had significantly elevated serum γ-GT level and higher increase rate than those of. any other enzyme tests. This may suggest the value of γ-GT as a screening test for neoplastic diseases of the liver. 4. Of all the patients studied, patients with carcinoma of pancreas revealed highest γ-GT values. 5. Patients with carcinomas except hepatocellular and pancreatic carcinomas did not reveal significant elevation of serum γ-GT activity. 6. In patients with bone diseases, γ-GT levels were within normal range in contrast to elevated alkaline phosphatase activities. 7. A portion of patients with neurologic diseases showed slightly elevated γ-GT level No significant change of γ-GT activity was noted in patients with renal failure. 8. In spite of the lack of specificity, it appears that the determination of γ-GT can indicate hepato-biliary dysfunction, especially used with other tests. 9. When the level of γ-GT is increased abruptly during the follow-up of a liver cirrhosis patient, the measurement of γ-GT may indicate the progress of liver cirrhosis or complication of hematoma, especially in a country like Korea which has a high incidence of liver.
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
CrossRef TDM  CrossRef TDM
Related article
The Diagnostic Value of Serum GGT Activity in Hepatobiliary Disease  1982 January;16(4)